Pancreatic Cancer Research

ResearcherHarbin Medical UniversityActive in the last 2 years

Gang Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1186-4336; OpenAlex author ID A5100367345. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
31
Papers, trials and grants by year

2016: 2 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 3 papers · 2023: 2 papers · 2024: none · 2025: 3 papers · 2026: 1 paper

Papers 12

  1. Spatial Multiomics Analyses Reveal That Diabetes Promotes Pancreatic Cancer Progression by Stimulating Cholesterol-Induced Neutrophil Extracellular Trap Format… Co-author DOI 10.1158/0008-5472.can-25-2854↗
  2. Alcohol-induced C/EBP β-driven VIRMA decreases oxidative stress and promotes pancreatic ductal adenocarcinoma growth and metastasis via the m6A/YTHDF2/SLC43A2 … Co-author DOI 10.1038/s41388-025-03283-6↗
  3. The lncRNA ST18-AS1 suppresses pancreatic cancer progression by enhancing ST18 mRNA stability through anchoring FUS in the cytoplasm. Last author DOI 10.1038/s41388-025-03455-4↗
  4. The role of LncRNA-MANCR induced by HIF-1α drive the malignant progression of pancreatic cancer by targeting miRNA-494/SIRT1 signaling axis under hypoxic condi… Last author DOI 10.1038/s41417-025-00900-0↗
  5. Tumor Cell Derived Lnc-FSD2-31:1 Contributes to Cancer-Associated Fibroblasts Activation in Pancreatic Ductal Adenocarcinoma Progression through Extracellular … Co-author DOI 10.1002/advs.202203324↗
  6. Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer. Co-author DOI 10.1186/s12967-023-04693-4↗
  7. Diabetic Ferroptosis and Pancreatic Cancer: Foe or Friend? Last author DOI 10.1089/ars.2022.0101↗
  8. Alcohol-induced C/EBP β-driven KIAA1429 decreases oxidative stress and promotes pancreatic cancer growth and metastasis via the m6A/YTHDF2/SLC43A2 pathway Co-author DOI 10.21203/rs.3.rs-1721317/v1↗
  9. Comprehensive Analysis of Necroptosis in Pancreatic Cancer for Appealing its Implications in Prognosis, Immunotherapy, and Chemotherapy Responses. Last author DOI 10.3389/fphar.2022.862502↗
  10. Overexpression of KLF5 is associated with poor survival and G1/S progression in pancreatic cancer. Co-author DOI 10.18632/aging.102096↗
  11. Long Noncoding RNA MALAT1 Promotes Aggressive Pancreatic Cancer Proliferation and Metastasis via the Stimulation of Autophagy. Co-author DOI 10.1158/1535-7163.mct-16-0008↗
  12. Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer. Co-author DOI 10.18632/oncotarget.12365↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Le Li · 5 shared papers, 2016–2026 · strength 0.86
  2. Yongwei Wang · 6 shared papers, 2016–2026 · strength 0.72
  3. Bei Sun · 6 shared papers, 2016–2023 · strength 0.68
  4. Jisheng Hu · 4 shared papers, 2019–2026 · strength 0.61
  5. Rui Kong · 5 shared papers, 2016–2026 · strength 0.58
  6. Guanqun Li · 3 shared papers, 2023–2026 · strength 0.53
  7. Yilong Li · 3 shared papers, 2019–2025 · strength 0.50
  8. Yan Jin · 2 shared papers, 2025 · strength 0.47
  9. Hongze Chen · 4 shared papers, 2016–2023 · strength 0.43
  10. Bei Sun · 2 shared papers, 2023–2026 · strength 0.38
  11. Wenbo Yang · 2 shared papers, 2023 · strength 0.29
  12. Le Li · 3 shared papers, 2016–2023 · strength 0.28
  13. Zhongjie Zhao · 3 shared papers, 2016–2023 · strength 0.28
  14. Lei Gao · 1 shared paper, 2025 · strength 0.27
  15. Yuhua Zhang · 1 shared paper, 2025 · strength 0.27
  16. Long Cheng · 1 shared paper, 2025 · strength 0.24
  17. Long Cheng · 1 shared paper, 2025 · strength 0.24
  18. Yan Luo · 1 shared paper, 2026 · strength 0.24
  19. Xuewei Bai · 2 shared papers, 2016–2023 · strength 0.19
  20. Le Li · 1 shared paper, 2022 · strength 0.19
  21. Kun Fang · 1 shared paper, 2022 · strength 0.17
  22. Liwei Liu · 1 shared paper, 2023 · strength 0.15
  23. Qiushi Tang · 1 shared paper, 2022 · strength 0.15
  24. Chundong Cheng · 1 shared paper, 2023 · strength 0.14
  25. Xinglong Geng · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.